Time and place:
January 2026, 8:30–9:15 am Online or meeting room Tarlebø, Alrek health cluster Language: Norwegian Coffee and tea will be served
Pandemic Breakfast: What does the new infection control law mean for law and public health?
UiB project receives over five million euros to reduce child mortality
UiB has received 5.3 million euros from the EU for the PRoRota project, which will investigate whether probiotics, better hygiene education and mathematical models can reduce child mortality related to diarrhea in low- and middle-income countries. The project tests whether probiotics can improve the effect of the rotavirus vaccine in a large study with 4,000 newborns in Tanzania, Malawi and Ivory Coast. In addition, a warning system for rotavirus outbreaks is being developed and research is being conducted on how WASH routines can work better in practice.
Announcement of the Neuro-SysMed seminar on 4 February
Wednesday 4 February – 11:30-13:00 – Auditorium in Armauer Hansens HusTranslating biomedical discoveries into scalable medical solutions is still slow, with many innovations stalling in the “translation gap”. Misaligned incentives, professional silos and weak links between academia, healthcare…
CCBIO Seminar January 29, 2026: Katrin Kleinmanns presents award-winning research
CCBIO welcomes you to the first spring seminar of 2026, which will take place on Thursday, January 29th in auditorium 4 at BBB. The event is open to all, and no registration is required. This time, CCBIO researcher Katrin Kleinmanns will be on stage, presenting the work that earned her the Young Cancer Researcher Award.
Welcome to CancerREHAB 2026 in Tromsø!
On April 13–14, 2026, professional communities from all over the country will gather at Scandic Ishavshotell when the national professional conference KreftREHAB is held in Tromsø for the first time. The conference is the year's most important meeting place for everyone working with cancer rehabilitation, and offers two days of professional in-depth study, inspiration and networking.
UiB receives over 170 million in the Research Council's December awards
UiB will receive over 170 million kroner from the Research Council in December for new innovation centers and research projects within health, technology, the seabed, society and top research.
Leader of the week – Eystein Husebye
The institute is concerned that the number of applications to the Research Council is decreasing and that grants have become smaller. This coincides with new application routines with ongoing calls for proposals and quarantine schemes. The Research Council reports that they are receiving about half as many applications as before, which also means that the grant percentage is increasing. This provides room for opportunity for K2's researchers to receive funding.
The table (available by clicking "read more") below lists schemes that have ongoing calls for proposals where applications can be expected within 1-5 months. This opens up opportunities for innovative research, radical ideas and, not least, good opportunities for stays abroad. This is an underutilized opportunity that can have enormous significance for a future research career.
In addition, the Research Council has calls for longterm funding through SFF and SFI. For the most ambitious environments, there are Centers of Excellence (SFF), with up to 10 years of funding (6+4 years). For the most recent call, the deadline was in November 2025 and K2 researchers are eagerly waiting to see if they have progressed to round 2.
In addition, the Centers for Research-Driven Innovation (SFI) and the Research Center for Clinical Treatment (FKB) provide opportunities for 8-year projects with strong industrial and clinical roots. Here, our friends at K1 just received funding for the Innovation Center for Neuroresilience. New initiatives for these programs have not yet been announced.
The Research Council will launch a new application system with a simpler format, better calculation tools and clearer assessment criteria in 2026. Project funding from the Research Council is particularly important for K2's finances as indirect costs are also covered.
I hope this inspires –
Eystein Husebye, deputy director at K2
Defence - Jakub Vasicek - 01/29/26
Jakub Vasicek
Dato: 29.januar
Place: Birkhaugsalen, Sentralblokken, HUS, Jonas Lies vei 65
Dissertation title: "Enabling Haplotype-Aware Proteomics to Better Connect Human Genomes and Proteomes"
Defence – Arne Carlsen – 21.01.26
Arne Carlsen
Date: 21.january
Location: Aula in Nye SUS, Ullandhaug, building C
Title of the thesis: "Therapeutic Drug Monitoring of Infliximab and Adalimumab in Inflammatory Bowel Disease. Impact on treatment decisions"
Defence – Annabel Eide Ohldieck – 23.01.26
Annabel Eide Ohldieck
Date: 23.january
Location: Auditorium, Armauer Hansens Hus, Haukelandsveien 28
Dissertation title: "Sex-specific associations of blood pressure and body mass index with cardiovascular complications: Insights from the Hordaland Health Study"
The pharmaceutical profession is exciting and wide-ranging!
Our own Lone Holst has helped collect material for the learning platform Farmasihistorie. Listen and read what 30 pharmacists have to offer in terms of stories from the world of pharmacy, at home and abroad.
IHI launches call 12: New opportunities for researchers and innovation communities
The European Innovative Health Initiative (IHI) has now opened Call 12, an applicant-driven, one-stage call with five themes. Each theme is linked to one of the five specific objectives of IHI's strategic research and innovation agenda. The application deadline is 21 April 2026.
Breakfast seminar for PhD supervisors puts AI on the agenda
The Faculty of Medicine at the University of Bergen invites PhD supervisors to a breakfast seminar on a current and popular topic: artificial intelligence in everyday research. The seminar will take place on Tuesday, February 11, 2026, 8:30–10:00 AM at Alrek Health Center.